Studies Heart Health in Women After Pregnancy Preeclampsia
Looks at blood markers to find women at risk of heart problems after preeclampsia.
Key facts
- Who runs it
- University of California, San Diego
- Where
- San Diego, United StatesSee the site
- Trial code
- Registry title
- Multi-Omics for Maternal Health After Preeclampsia
- Status
- Recruiting
- People taking part
- 1,100 people, planned
- Started
- 20 Dec 2023
- Expected to end
- Dec 2028
- Type of study
- Observational, 2 groups
- Record updated
- 6 April 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for pregnant women aged 18 to 50 who are 10-24 weeks into a single pregnancy and plan to deliver at a study site.
- Age
- 18 to 50 years
- Sex
- Women only
- Disease stage
- Pregnancy at 10-24 weeks, one baby (singleton pregnancy).
Main reasons for not taking part
- Cannot give informed consent
- Multiple babies (multi-fetal pregnancy) or a twin demise
- Known or suspected genetic or structural problem in the baby, or a known chromosome problem in the mother or baby
- Active or past cancer that needed major surgery or systemic chemotherapy
- Plans to keep the placenta after delivery
This trial only enrols pregnant participants. The registry sentence this rests on: Pregnant women 18 years of age to 50 years of age
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Pregnant women 18 years of age to 50 years of age
- 10-24 weeks gestation at time of enrollment
- Singleton pregnancy
- Planning to deliver at a study site (UCSD or VUMC)
Who cannot take part
- Institutionalization for psychiatric disorder, mental deficiency or incarcerated
- Active or history of malignancy requiring major surgery or systemic chemotherapy
- Multi-fetal gestation or a twin demise at any gestational age
- Inability to give informed consent
- Intrauterine fetal demise
- Fetal genetic or structural anomaly
- Known maternal or fetal chromosomal anomalies
- Patients who plan to keep their placenta after delivery
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
Where in United States
- University of California San DiegoSan Diego, United StatesContact: Maya SelvarajTaking people
About the trial
What the trial wants to find out
To develop strategies to identify postpartum women at risk for adverse cardiovascular outcomes and provide them with preventative therapies.
The 2 groups in the trial
- Low-risk pregnancy
Pregnant subjects with none of the following: chronic hypertension, pregestational diabetes, renal disease, autoimmune disease, history of preterm preeclampsia in a prior pregnancy
- High-risk pregnancy
Pregnant subjects with one or more of the following: chronic hypertension, pregestational diabetes, renal disease, autoimmune disease, history of preterm preeclampsia in a prior pregnancy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Multi-Omics for Maternal Health After Preeclampsia
- Plain-language title
- Studies Heart Health in Women After Pregnancy PreeclampsiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06340152, who can take part
- Record updated
- 6 April 2025